Packages (Simulation)
![ELISA Kit for Complement Component 4a (C4a)](/upload/static/product/SE.jpg)
Reagent Preparation
![ELISA Kit for Complement Component 4a (C4a)](/upload/static/reagent/TB.jpg)
Image (I)
Image (II)
Certificate
![Certificate](/upload/static/ISO13485.jpg)
![Certificate](/upload/static/ce-1.jpg)
ELISA Kit for Complement Component 4a (C4a)
C4a anaphylatoxin
- Product No.SEA389Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range31.2-2,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 13.3pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 454
For more details, please contact local distributors! US$ 648 US$ 2916 US$ 5508 US$ 45360
Specificity
This assay has high sensitivity and excellent specificity for detection of Complement Component 4a (C4a).
No significant cross-reactivity or interference between Complement Component 4a (C4a) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Complement Component 4a (C4a) and the recovery rates were calculated by comparing the measured value to the expected amount of Complement Component 4a (C4a) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 82-96 | 89 |
EDTA plasma(n=5) | 82-101 | 95 |
heparin plasma(n=5) | 84-94 | 88 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Complement Component 4a (C4a) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Complement Component 4a (C4a) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Complement Component 4a (C4a) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 83-102% | 98-105% | 93-101% | 99-105% |
EDTA plasma(n=5) | 78-103% | 96-105% | 87-95% | 79-96% |
heparin plasma(n=5) | 99-105% | 94-101% | 88-97% | 95-105% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis PubMed: 20100644 |
PLoS ONE | Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance PubMed: PMC3754973 |
PLoS One | Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis PubMed: 26098644 |
PLoS One | Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis PubMed: 25789864 |
Experimental Eye Research | Quantitative analysis of hydroxyapatite-binding plasma proteins in genotyped individuals with late-stage age-related macular degeneration Pubmed:29580721 |
Diagnostics | Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J Pubmed: 32585848 |
Scientific Reports | Maternal Serum Proteomic Profiles of Pregnant Women With Type 1 Diabetes 34940989 |
Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
APA389Mu02 | Active Complement Component 4a (C4a) | Cell culture; Activity Assays. |
RPA389Mu01 | Recombinant Complement Component 4a (C4a) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA389Mu02 | Recombinant Complement Component 4a (C4a) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA389Mu02 | Polyclonal Antibody to Complement Component 4a (C4a) | WB; IHC; ICC; IP. |
PAA389Mu01 | Polyclonal Antibody to Complement Component 4a (C4a) | WB; IHC |
SEA389Mu | ELISA Kit for Complement Component 4a (C4a) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA389Mu | Multiplex Assay Kit for Complement Component 4a (C4a) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |